1
|
Toumba M, Kokotsis V, Savva SC and Skordis
N: Expensive therapies in children: Benefit versus cost of combined
treatment of recombinant human growth hormone and
gonadotropin-releasing hormone analogue in girls with poor height
potential. J Pediatr Endocrinol Metab. 27:311–316. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sandberg DE and Gardner M: Short stature:
Is it a psychosocial problem and does changing height matter?
Pediatr Clin North Am. 62:963–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gohlke BC and Stanhope R: Final height in
psychosocial short stature: Is there complete catch-up? Acta
Paediatr. 91:961–965. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Baten J, Pelger I and Twrdek L: The
anthropometric history of Argentina, Brazil and Peru during the
19th and early 20th century. Econ Hum Biol. 7:319–333. 2009.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Quitmann JH, Bullinger M, Sommer R,
Rohenkohl AC and Bernardino Da Silva NM: Associations between
psychological problems and quality of life in pediatric short
stature from patients' and parents' perspectives. PLoS One.
11:e01539532016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Cohen LE: Idiopathic short stature: A
clinical review. JAMA. 311:1787–1796. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Cuttler L: Safety and efficacy of growth
hormone treatment for idiopathic short stature. J Clin Endocrinol
Metab. 90:5502–5504. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bereket A, Turan S, Omar A, Berber M, Ozen
A, Akbenlioglu C and Haklar G: Serum IGF-I and IGFBP-3 levels of
Turkish children during childhood and adolescence: Establishment of
reference ranges with emphasis on puberty. Horm Res. 65:96–105.
2006.PubMed/NCBI
|
9
|
Cappa M, Iughetti L, Loche S, Maghnie M
and Vottero A; GeNeSIS National Board on behalf of the GeNeSIS
Italian Investigators, : Efficacy and safety of growth hormone
treatment in children with short stature: The Italian cohort of the
GeNeSIS clinical study. J Endocrinol Invest. 39:667–677. 2016.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Wit JM and Rekers-Mombarg LT; Dutch Growth
Hormone Advisory Group, : Final height gain by GH therapy in
children with idiopathic short stature is dose dependent. J Clin
Endocrinol Metab. 87:604–611. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kozuki N, Katz J, Lee AC, Vogel JP,
Silveira MF, Sania A, Stevens GA, Cousens S, Caulfield LE,
Christian P, et al Child Health Epidemiology Reference Group
Small-for-Gestational-Age/Preterm Birth Working Group, : Short
maternal stature increases risk of small-for-gestational-age and
preterm births in low- and middle-income countries: Individual
participant data meta-analysis and population attributable
fraction. J Nutr. 145:2542–2550. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Xu S, Gu X, Pan H, Zhu H, Gong F, Li Y and
Xing Y: Reference ranges for serum IGF-1 and IGFBP-3 levels in
Chinese children during childhood and adolescence. Endocr J.
57:221–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Şıklar Z, Kocaay P, Çamtosun E, İsakoca M,
Hacıhamdioğlu B, Savaş Erdeve Ş and Berberoğlu M: The effect of
recombinant growth hormone treatment in children with idiopathic
short stature and low insulin-like growth factor-1 levels. J Clin
Res Pediatr Endocrinol. 7:301–306. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Grimberg A, DiVall SA, Polychronakos C,
Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C and Murad MH;
Drug and Therapeutics Committee and Ethics Committee of the
Pediatric Endocrine Society, : Guidelines for growth hormone and
insulin-like growth factor-I treatment in children and adolescents:
growth hormone deficiency, idiopathic short stature, and primary
insulin-like growth factor-I deficiency. Horm Res Paediatr.
86:361–397. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Huchko MJ, Leslie H, Maloba M, Zakaras J,
Bukusi E and Cohen CR: Outcomes up to 12 months after treatment
with loop electrosurgical excision procedure for cervical
intraepithelial neoplasia among HIV-infected women. J Acquir Immune
Defic Syndr. 69:200–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cengiz P, Bas F, Atalar F, Ucar A,
Darendeliler F, Akan G, Tarhan T and Bundak R: Growth
hormone/insulin-like growth factor-1 axis as related to body mass
index in patients with idiopathic short stature. J Clin Res Pediatr
Endocrinol. 5:13–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kawashima Y, Hakuno F, Okada S, Hotsubo T,
Kinoshita T, Fujimoto M, Nishimura R, Fukushima T, Hanaki K,
Takahashi S, et al: Familial short stature is associated with a
novel dominant- negative heterozygous insulin-like growth factor 1
receptor (IGF1R) mutation. Clin Endocrinol (Oxf). 81:312–314. 2014.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Takeshita H, Fujihara J, Soejima M, Koda
Y, Kimura-Kataoka K, Ono R, Yuasa I, Iida R, Ueki M, Nagao M, et
al: Confirmation that SNPs in the high mobility group-A2 gene
(HMGA2) are associated with adult height in the Japanese
population; wide-ranging population survey of height-related SNPs
in HMGA2. Electrophoresis. 32:1844–1851. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Teng RJ, Wu TJ and Hsieh FJ: Cord blood
level of insulin-like growth factor-1 and IGF binding protein-3 in
monochorionic twins. J Formos Med Assoc. 114:359–362. 2015.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Kaplan RC, Petersen AK, Chen MH, Teumer A,
Glazer NL, Döring A, Lam CS, Friedrich N, Newman A, Müller M, et
al: A genome-wide association study identifies novel loci
associated with circulating IGF-I and IGFBP-3. Hum Mol Genet.
20:1241–1251. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Herfs M, Somja J, Howitt BE,
Suarez-Carmona M, Kustermans G, Hubert P, Doyen J, Goffin F,
Kridelka F, Crum CP, et al: Unique recurrence patterns of cervical
intraepithelial neoplasia after excision of the squamocolumnar
junction. Int J Cancer. 136:1043–1052. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bohé J, Joly MO, Arkouche W, Laville M and
Fouque D: Haemodialysis with the biocompatible high permeability
AN-69 membrane does not alter plasma insulin-like growth factor-I
and insulin-like growth factor binding protein-3. Nephrol Dial
Transplant. 16:590–594. 2001. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kim SA, Choe YR, Yang EM and Kim CJ:
Comparison of growth hormone treatment in patients with idiopathic
short stature and idiopathic growth hormone deficiency. Chonnam Med
J. 50:63–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hoffman AR: Treatment of the adult growth
hormone deficiency syndrome: Directions for future research. Growth
Horm IGF Res. 15 (Suppl A):48–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Sotos JF and Tokar NJ: Growth hormone
significantly increases the adult height of children with
idiopathic short stature: Comparison of subgroups and benefit. Int
J Pediatr Endocrinol. 2014:152014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lanes R, Gunczler P, Esaa S and Weisinger
JR: The effect of short- and long-term growth hormone treatment on
bone mineral density and bone metabolism of prepubertal children
with idiopathic short stature: A 3-year study. Clin Endocrinol
(Oxf). 57:725–730. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Rasat R, Livesey JL, Espiner EA, Abbott GD
and Donald RA: IGF-1 and IGFBP-3 screening for disorders of growth
hormone secretion. N Z Med J. 109:156–159. 1996.PubMed/NCBI
|